Arkolith/Insider Trading/INDP/Form 4

Meckler Jeffrey A

Chief Executive Officer, DirectorIndaptus Therapeutics, Inc. (INDP) · full profile →Form 4 · filed Jul 29, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 27, 2025Grant(A)6K$8.30$50K13K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 27, 2025Grant(A)12K$8.30$101K17K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641172-25-021376) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML